Back to Authors

Lamb, Carla

Mayo Clinic

Lahey Hospital and Medical Center

Citations 5

Interventional Pulmonary Fellowship Training: End of the Beginning
Lee, Hans J. , Akulian, Jason , Argento, A. Christine , Batra, Hitesh , Lamb, Carla, Mullon, John J., Murgu, Septimiu , Mullon, John

ATS Scholar | September 7, 2023 | Volume: 4 | Issue: 4 | Pages: 405-412

10.34197/ats-scholar.2022-0107ps Get It

Abstract Interventional pulmonology (IP) fellowship training has undergone increased popularity and growth. The Accreditation Council of Graduate Medical Education recently recognized IP medicine as a new subspecialty, which leads to new challenges and opportunities for a young subspecialty. Although the specialty-specific requirements are in progress, IP fellowship programs must plan ahead for the known common program requirements and anticipated accreditation process. The educational leadership in IP must identify and execute solutions to sustain continued excellence. This includes transitioning to a new regulatory environment with issues of funding new fellowships, keeping up to date with training/assessment of new procedures, and shaping the future through recruitment of talent to lead the young subspecialty.
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial
Criner, Gerard J. , Delage, Antoine, Voelker, Kirk , Majid, Adnan , Zgoda, Michael, Lazarus, Donald R. , Casal, Roberto F. , Benzaquen, Sadia , Holladay, Robert, Wellikoff, Adam, Calero, Karel , Rumbak, Mark J., Branca, Paul, Abu‐Hijleh, Muhanned , Sachdeva, Ashutosh , Kinsey, C. Matthew , Lamb, Carla, Reed, Michael F. , Abouzgheib, Wissam , Kaplan, Phillip V., Marrujo, Gregory X., Johnstone, David W., Gasparri, Mario, Meade, Arturo A., Reddy, Chakravarthy, Case, Amy Hajari , Makani, Samir, Shepherd, Ray W., Holt, Gregory E. , Martel, Simon , Herth, Felix , Mallea, Jorge M. , Kalhan, Ravi , Criner, Gerard , Hogarth, D. Kyle , Kalhan, Ravi , Hergott, Christopher A. , Mularski, Richard A. , Chen, Benson S.

American Journal of Respiratory and Critical Care Medicine | July 31, 2019 | Volume: 200 | Issue: 11 | Pages: 1354-1362

10.1164/rccm.201902-0383oc Get It

Abstract Rationale Less invasive, nonsurgical approaches are needed to treat severe emphysema. Objectives To evaluate the effectiveness and safety of the Spiration Valve System (SVS) versus optimal medical management. Methods In this multicenter, open-label, randomized, controlled trial, subjects aged 40 years or older with severe, heterogeneous emphysema were randomized 2:1 to SVS with medical management (treatment) or medical management alone (control). Measurements and Main Results The primary efficacy outcome was the difference in mean FEV1 from baseline to 6 months. Secondary effectiveness outcomes included: difference in FEV1 responder rates, target lobe volume reduction, hyperinflation, health status, dyspnea, and exercise capacity. The primary safety outcome was the incidence of composite thoracic serious adverse events. All analyses were conducted by determining the 95% Bayesian credible intervals (BCIs) for the difference between treatment and control arms. Between October 2013 and May 2017, 172 participants (53.5% male; mean age, 67.4 yr) were randomized to treatment (n = 113) or control (n = 59). Mean FEV1 showed statistically significant improvements between the treatment and control groups—between-group difference at 6 and 12 months, respectively, of 0.101 L (95% BCI, 0.060–0.141) and 0.099 L (95% BCI, 0.048–0.151). At 6 months, the treatment group had statistically significant improvements in all secondary endpoints except 6-minute-walk distance. Composite thoracic serious adverse event incidence through 6 months was greater in the treatment group (31.0% vs. 11.9%), primarily due to a 12.4% incidence of serious pneumothorax. Conclusions In patients with severe heterogeneous emphysema, the SVS shows significant improvement in multiple efficacy outcomes, with an acceptable safety profile. Clinical trial registered with www.clinicaltrials.gov (NCT01812447).
Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial
Wahidi, Momen M. , Reddy, Chakravarthy, Yarmus, Lonny , Feller‐Kopman, David , Musani, Ali I., Shepherd, Ray W., Bechara, Rabih , Lamb, Carla, Shofer, Scott , Mahmood, Kamran , Michaud, Gaëtane , Puchalski, Jonathan , Rafeq, Samaan , Cattaneo, Stephen M., Mullon, John J., Leh, Steven, Mayse, Martin L., Thomas, Samantha , Peterson, Bercedis L., Light, Richard W., Mullon, John, Lee, Hans C.

American Journal of Respiratory and Critical Care Medicine | March 6, 2017 | Volume: 195 | Issue: 8 | Pages: 1050-1057

10.1164/rccm.201607-1404oc Get It

Abstract Rationale Patients with malignant pleural effusions have significant dyspnea and shortened life expectancy. Indwelling pleural catheters allow patients to drain pleural fluid at home and can lead to autopleurodesis. The optimal drainage frequency to achieve autopleurodesis and freedom from catheter has not been determined. Objectives To determine whether an aggressive daily drainage strategy is superior to the current standard every other day drainage of pleural fluid in achieving autopleurodesis. Methods Patients were randomized to either an aggressive drainage (daily drainage; n = 73) or standard drainage (every other day drainage; n = 76) of pleural fluid via a tunneled pleural catheter. Measurements and Main Results The primary outcome was the incidence of autopleurodesis following the placement of the indwelling pleural catheters. The rate of autopleurodesis, defined as complete or partial response based on symptomatic and radiographic changes, was greater in the aggressive drainage arm than the standard drainage arm (47% vs. 24%, respectively; P = 0.003). Median time to autopleurodesis was shorter in the aggressive arm (54 d; 95% confidence interval, 34–83) as compared with the standard arm (90 d; 95% confidence interval, 70 to nonestimable). Rate of adverse events, quality of life, and patient satisfaction were not significantly different between the two arms. Conclusions Among patients with malignant pleural effusion, daily drainage of pleural fluid via an indwelling pleural catheter led to a higher rate of autopleurodesis and faster time to liberty from catheter. Clinical trial registered with www.clinicaltrials.gov (NCT 00978939).
Reply: Endobronchial Ultrasound Skills and Tasks Assessment Tool (EBUS-STAT)
Davoudi, Mohsen, Colt, Henri G. , Osann, Kathryn , Lamb, Carla, Mullon, John J.

American Journal of Respiratory and Critical Care Medicine | July 15, 2013 | Volume: 188 | Issue: 2 | Pages: 256-257

10.1164/rccm.201302-0376le Get It

Endobronchial Ultrasound Skills and Tasks Assessment Tool: Assessing the Validity Evidence for a Test of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Operator Skill
Davoudi, Mohsen, Colt, Henri G. , Osann, Kathryn , Lamb, Carla, Mullon, John J.

American Journal of Respiratory and Critical Care Medicine | July 27, 2012 | Volume: 186 | Issue: 8 | Pages: 773-779

10.1164/rccm.201111-1968oc Get It

Abstract Rationale Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is becoming standard of care for the sampling of mediastinal adenopathy. The need for a safe, effective, accurate procedure makes EBUS-TBNA ideal for mastery training and testing. Objectives The Endobronchial Ultrasound Skills and Tasks Assessment Tool (EBUS-STAT) was created as an objective competency-oriented assessment tool of EBUS-TBNA skills and knowledge. This study demonstrates the reliability and validity evidence of this tool. Methods The EBUS-STAT objectively scores the EBUS-TBNA operator’s skills, including atraumatic airway introduction and navigation, ultrasound image acquisition and optimization, identification of mediastinal nodal and vascular structures, EBUS-TBNA sampling, and recognition of EBUS/computed tomography images of mediastinal structures. It can be administered at the bedside or using combination of low- and high-fidelity simulation platforms. Two independent testers administered the EBUS-STAT to 24 operators at three levels of EBUS-TBNA experience (8 beginners, 8 intermediates, and 8 experienced) at three institutions; operators were also asked to self-assess their skills. Scores were analyzed for intertester reliability, correlation with prior EBUS-TBNA experience, and association with self-assessments. Measurements and Main Results Intertester reliability between testers was very high (r = 0.9991, P < 0.00005). Mean EBUS-STAT scores for beginner, intermediate, and experienced groups, respectively, were 31.1, 74.9, and 93.6 out of 100 (F2,21 = 118.6, P < 0.0001). Groups were nonoverlapping: post hoc tests showed each group differed significantly from the others (P < 0.001). Self-assessments corresponded closely to actual EBUS-STAT scores (r2 = 0.81, P < 0.001). Conclusions The EBUS-STAT can be used to reliably and objectively score and classify EBUS-TBNA operators from novice to expert. Its use to assess and document the acquisition of knowledge and skill is a step toward the goal of mastery training in EBUS-TBNA.